Leonard, P.F. millions of DNA fragments can be sequenced, characterized and sorted in a single Megacloner run, enabling many new applications. Currentde novogene construction14rests on chemical oligonucleotide synthesis of the 1990s retaining error rates of 1 1 error in 300 base pairs and significant costs. Errors are typically avoided using manual selection of the best Sanger sequences using electrophoretic automation. Recent innovations in programmable array technology58offer the possibility to synthesize pools of thousands to millions of sequences per array with lengths comparable to conventional synthesis. The technology thus provides an extremely rich source of DNA oligonucleotides with great flexibility and superior efficiency regarding throughput and cost per basepair. However, the error rate of microarray-derived oligonucleotides is typically higher compared to conventional synthesis, making error avoidance or correction necessary. Furthermore it is challenging to divide the derived oligonucleotide Rabbit Polyclonal to KR2_VZVD pools, containing vast amounts of species, into sub pools — necessary, for example, to guide the assembly of synthetic genes, chromosomal regions or whole pathways in synthetic biology. The new method described here, termed Megacloning, turns NGS from a previously purely analytical method into a preparative tool, and represents a tremendous source of sequence-verified DNA where the yield from one NGS run is equivalent to that AZD-7648 from hundreds to thousands of Sanger-sequence runs. It therefore addresses the challenge of error reduction for both conventional and microarray-derived DNA oligonucleotides. The output of the method are high quality DNA libraries containing perfect parts with desired and correct sequences in adjustable ratios useful for a wide range of (bio-)technological applications. Here we present a proof-of-concept study aimed at the retrieval of clonal DNA with known sequence from an NGS platform post-sequencing (Fig.1). The workflow comprises input DNA of short length, an NGS run to generate sequence verified DNA clones, the localization of DNA with desired sequence on the sequencers substrate and finally the subsequent retrieval of the clones of choice. The sources for the input DNA are fairly independent of the Megacloning step. For the present work, input DNA was derived from conventional oligonucleotide synthesis and from DNA microarrays. The NGS platform used was the GS FLX device from Roche 454 Life Sciences9,10. Due to its open-top architecture, accessibility of the beads and the bead size, this platform is well suited for a pick-and-place approach using micropipettes to retrieve beads specifically from the 454-Picotiterplate (PTP) and transfer them into conventional multi-well plates for further processing. == Figure 1. == Strategy overview. The general approach includes DNA from AZD-7648 a variety of sources. After Next Generation Sequencing the DNA will be sorted and retrieved selectively whereas the technologies used depend on the NGS platform. The particular approach described here includes microarrays as well as standard sources of oligonucleotides. For sequencing prior sorting and selection the GS FLX platform (454/Roche) was used. First we founded a technical setup for the controlled extraction of beads. The PTP at this stage contained a “natural” sample, and extraction was done using a micropipette controlled by a micro actuator device (supplementary Fig.1 and 2 online). To assess the fidelity of our setup we compared AZD-7648 the reads coming from the GS FLX platform with Sanger-derived sequences of DNA amplified from extracted beads. The alignment of Sanger sequences to the NGS reads matched 99.9%. Only two mismatches were acquired in 2,410 basepairs. Both were putative insertions in the GS FLX reads happening at homopolymer AZD-7648 stretches and therefore possess a high probability of becoming platform-specific base phoning artefacts9(supplementary note on-line). Next we collected a set of 319 beads with DNA clones from a microarray derived pool.